Shanrong Biotechnology Corp.
SRBT · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2018 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $24 | $16 | $79 | $223 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $223 |
| Operating Expenses | $24 | $16 | $79 | $447 |
| Operating Income | -$24 | -$16 | -$79 | -$447 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $0 | $0 | $223 |
| Pre-Tax Income | -$24 | -$16 | -$79 | -$223 |
| Tax Expense | $0 | $0 | $0 | -$223 |
| Net Income | -$24 | -$16 | -$79 | $0 |
| % Margin | – | – | – | – |
| EPS | -0.049 | -0.034 | -0.16 | 0 |
| % Growth | -43.5% | 78.9% | – | – |
| EPS Diluted | -0.049 | -0.034 | -0.16 | 0 |
| Weighted Avg Shares Out | 485 | 485 | 485 | 485 |
| Weighted Avg Shares Out Dil | 485 | 485 | 485 | 485 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $168 | $228 | $161 |
| EBITDA | -$24 | -$16 | -$79 | -$447 |
| % Margin | – | – | – | – |